Floatz logo

CARVEDILOL

Spontaneous Bacterial Peritonitis

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Spontaneous Bacterial Peritonitis cohort.

Asset / SponsorPhaseRating
Norfloxacin
Sherief Abd-Elsalam
Phase 4BBB
PROPRANOLOL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4BB
Rifaximin
Centre Hospitalier Universitaire de Besancon
Phase 3B
Vivomixx
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 3B
Ciprofloxacin
Seoul National University Hospital
Phase 3B

View all 10 →

Same molecule, other indications

CARVEDILOL is also rated in:

portal hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
73 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →